GlassScriptPhysician profile
Doreen E Chung
NPI 1215188214
$13,555.27
in general payments reported to CMS, 2019-2025
25 companies · $2,892 in 2025
The $2,892 reported for 2025 was more than what 77% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,072 · 2020: $549 · 2021: $636 · 2022: $1,473 · 2023: $4,179 · 2024: $1,756 · 2025: $2,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,911 · Travel and Lodging: $2,890 · Consulting Fee: $2,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,910.50 |
| Travel and Lodging | $2,890.36 |
| Consulting Fee | $2,025.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,961.24 | 2022-2024 | Bulkamid, Axonics |
| Boston Scientific Corporation | $2,926.61 | 2019-2025 | Capio Rp, Axonics, Ams 800 Artificial Urinary Sphincter |
| Abbvie INC. | $1,075.77 | 2022-2025 | Botox |
| Medtronic, INC. | $991.35 | 2021-2025 | Interstim, Altaviva |
| Coloplast Corp | $896.71 | 2019-2024 | |
| Allergan, INC. | $894.19 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $766.92 | 2023-2025 | Gemtesa |
| Lumenis, INC | $639.05 | 2019 | |
| Procept Biorobotics Corporation | $584.10 | 2019-2024 | Aquabeam Robotic System, Aquabeam System |
| Urovant Sciences INC | $538.12 | 2021-2022 | |
| Astellas Pharma US INC | $396.14 | 2019-2021 | |
| Cook Medical LLC | $276.76 | 2023 | Cook |
| Medtronic USA, INC. | $190.94 | 2019-2020 | |
| Hollister Incorporated | $122.44 | 2019-2023 | Onli, Vapro Plus Pocket, Vapro |
| Pfizer INC. | $65.39 | 2020-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $41.72 | 2019 | |
| Ambu INC. | $36.73 | 2024 | |
| Rochester Medical Corporation | $34.34 | 2019-2020 | |
| Janssen Biotech, INC. | $25.03 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $23.62 | 2021 | |
| Urogen Pharma, INC. | $19.20 | 2022 | |
| Dentsply Ih INC. | $18.40 | 2019 | |
| Antares Pharma, INC. | $18.24 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $12.26 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doreen Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.